These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9563577)

  • 1. Evoked potentials in clinical trials for multiple sclerosis.
    Emerson RG
    J Clin Neurophysiol; 1998 Mar; 15(2):109-16. PubMed ID: 9563577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS.
    Hardmeier M; Leocani L; Fuhr P
    Mult Scler; 2017 Sep; 23(10):1309-1319. PubMed ID: 28480798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring evoked responses in multiple sclerosis.
    Comi G; Leocani L; Medaglini S; Locatelli T; Martinelli V; Santuccio G; Rossi P
    Mult Scler; 1999 Aug; 5(4):263-7. PubMed ID: 10467386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal Evoked Potentials as Candidate Prognostic and Response Biomarkers in Clinical Trials of Multiple Sclerosis.
    Hardmeier M; Fuhr P
    J Clin Neurophysiol; 2021 May; 38(3):171-180. PubMed ID: 33958567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Neurophysiology of Multiple Sclerosis.
    Habek M; Adamec I; Barun B; Crnošija L; Gabelić T; Krbot Skorić M
    Adv Exp Med Biol; 2017; 958():129-139. PubMed ID: 28093711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evoked potentials in multiple sclerosis.
    Kraft GH
    Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):717-20. PubMed ID: 24314688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical neurophysiology of multiple sclerosis.
    Leocani L; Comi G
    Handb Clin Neurol; 2014; 122():671-9. PubMed ID: 24507539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Motor-Evoked Potentials in Clinical Trials in Multiple Sclerosis.
    Fernández V
    J Clin Neurophysiol; 2021 May; 38(3):166-170. PubMed ID: 33958566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of evoked potentials in the diagnosis and follow-up of multiple sclerosis.
    Drislane FW
    Clin Neurosci; 1994; 2(3-4):196-201. PubMed ID: 7749888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early abnormalities in evoked potentials and future disability in patients with multiple sclerosis.
    Casanova B; Bosca I; Parra S; Pascual A; Coret F
    Mult Scler; 2006 Aug; 12(4):521-2. PubMed ID: 16900770
    [No Abstract]   [Full Text] [Related]  

  • 11. Evoked potentials to test a treatment of chronic multiple sclerosis.
    Anderson DC; Slater GE; Sherman R; Ettinger MG
    Arch Neurol; 1987 Dec; 44(12):1232-6. PubMed ID: 3675257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evoked potentials for evaluation of multiple sclerosis.
    Fuhr P; Kappos L
    Clin Neurophysiol; 2001 Dec; 112(12):2185-9. PubMed ID: 11738188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evoked potentials in monitoring multiple sclerosis.
    Leocani L; Medaglini S; Comi G
    Neurol Sci; 2000; 21(4 Suppl 2):S889-91. PubMed ID: 11205369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evoked potential abnormality scores are a useful measure of disease burden in relapsing-remitting multiple sclerosis.
    O'Connor P; Marchetti P; Lee L; Perera M
    Ann Neurol; 1998 Sep; 44(3):404-7. PubMed ID: 9749611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis.
    Kallmann BA; Fackelmann S; Toyka KV; Rieckmann P; Reiners K
    Mult Scler; 2006 Feb; 12(1):58-65. PubMed ID: 16459720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers and Surrogate End points in Multiple Sclerosis Trials: Regulatory Issues.
    Skeen MB; Pani L
    J Clin Neurophysiol; 2021 May; 38(3):181-185. PubMed ID: 33958568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurophysiology in multiple sclerosis.
    Eisen A
    Neurol Clin; 1983 Aug; 1(3):615-29. PubMed ID: 6095010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.
    Schlaeger R; Hardmeier M; D'Souza M; Grize L; Schindler C; Kappos L; Fuhr P
    Clin Neurophysiol; 2016 Mar; 127(3):1864-71. PubMed ID: 26754876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evoked potentials in multiple sclerosis: progress or stagnation?].
    Zakrzewska-Pniewska B
    Przegl Lek; 2010; 67(9):729-31. PubMed ID: 21387814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor evoked potentials and disability in secondary progressive multiple sclerosis.
    Facchetti D; Mai R; Micheli A; Marcianó N; Capra R; Gasparotti R; Poloni M
    Can J Neurol Sci; 1997 Nov; 24(4):332-7. PubMed ID: 9398981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.